PROTOKYNE RESEARCH PRIVATE LIMITED

In their own words

The proposed startup is a biotechnology venture focused on the development and manufacturing of high-quality fluorescent antibodies for research and diagnostic applications, along with monoclonal antibodies for clinical therapeutics. The company aims to address the critical gaps in India’s life sciences ecosystem, where dependence on imported antibodies results in high costs, long procurement timelines, and limited accessibility for researchers, diagnostic labs, and healthcare providers. Leveraging advanced expertise in immunology and flow cytometry, the startup will design, produce, and validate a wide range of fluorescently labeled antibodies tailored for applications such as immunophenotyping, cell sorting, and disease diagnostics. In parallel, the company will initiate the development of therapeutic monoclonal antibodies targeting clinically relevant pathways (e.g., inflammatory and bone-related disorders), with a long-term goal of contributing to affordable biologics in India. The startup’s core innovation lies in establishing an integrated, end-to-end antibody production platform within India, ensuring stringent quality control, batch consistency, and customization capabilities. This localized approach will significantly reduce costs and turnaround times while enabling rapid response to emerging research and clinical needs. By combining scientific expertise with scalable manufacturing and a strong focus on quality, the startup seeks to become a reliable domestic alternative to global antibody suppliers. It will support India’s growing biotech and healthcare sectors while contributing to the broader vision of self-reliance in high-value biologics. In the initial phase, the company will focus on building a robust product portfolio of research and diagnostic-grade fluorescent antibodies, followed by expansion into therapeutic antibody development through strategic collaborations, regulatory pathways, and clinical validation.

Written by the company on its public Startup India profile. Not verified by us.